Biocompatibility of Chitosan Carriers with Application in Drug Delivery

被引:290
作者
Rodrigues, Susana [1 ]
Dionisio, Marita [1 ]
Remunan Lopez, Carmen [2 ]
Grenha, Ana [1 ]
机构
[1] Univ Algarve, Ctr Mol & Struct Biomed CBME, IBB, Fac Sci & Technol, Campus Gambelas, P-8005139 Faro, Portugal
[2] Univ Santiago de Compostela, Dept Pharm & Pharmaceut Technol, Fac Pharm, Santiago De Compostela 15782, Spain
关键词
biocompatibility; chitosan; cytotoxicity; genotoxicity; microparticles; nanoparticles;
D O I
10.3390/jfb3030615
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Chitosan is one of the most used polysaccharides in the design of drug delivery strategies for administration of either biomacromolecules or low molecular weight drugs. For these purposes, it is frequently used as matrix forming material in both nano and micron-sized particles. In addition to its interesting physicochemical and biopharmaceutical properties, which include high mucoadhesion and a great capacity to produce drug delivery systems, ensuring the biocompatibility of the drug delivery vehicles is a highly relevant issue. Nevertheless, this subject is not addressed as frequently as desired and even though the application of chitosan carriers has been widely explored, the demonstration of systems biocompatibility is still in its infancy. In this review, addressing the biocompatibility of chitosan carriers with application in drug delivery is discussed and the methods used in vitro and in vivo, exploring the effect of different variables, are described. We further provide a discussion on the pros and cons of used methodologies, as well as on the difficulties arising from the absence of standardization of procedures.
引用
收藏
页码:615 / 641
页数:27
相关论文
共 135 条
[1]   Low-potency glucocorticoid hydrocortisone has similar neurotoxic effects as high-potency glucocorticoid dexamethasone on neurons in the immature chicken cerebellum [J].
Aden, Petra ;
Goverud, Ingeborg ;
Liestol, Knut ;
Loberg, Else Marit ;
Paulsen, Ragnhild E. ;
Moehlen, Jan ;
Lomo, Jon .
BRAIN RESEARCH, 2008, 1236 :39-48
[2]   STUDIES ON CHITOSAN .4. LYSOZYMIC HYDROLYSIS OF PARTIALLY N-ACETYLATED CHITOSANS [J].
AIBA, S .
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 1992, 14 (04) :225-228
[3]   Effects of nanomaterial physicochemical properties on in vivo toxicity [J].
Aillon, Kristin L. ;
Xie, Yumei ;
El-Gendy, Nashwa ;
Berkland, Cory J. ;
Forrest, M. Laird .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (06) :457-466
[4]   Microencapsulated chitosan nanoparticles for pulmonary protein delivery: In vivo evaluation of insulin-loaded formulations [J].
Al-Qadi, S. ;
Grenha, A. ;
Carrion-Recio, D. ;
Seijo, B. ;
Remunan-Lopez, C. .
JOURNAL OF CONTROLLED RELEASE, 2012, 157 (03) :383-390
[5]   COMPARISON OF TRYPAN BLUE-DYE EXCLUSION AND FLUOROMETRIC ASSAYS FOR MAMMALIAN-CELL VIABILITY DETERMINATIONS [J].
ALTMAN, SA ;
RANDERS, L ;
RAO, G .
BIOTECHNOLOGY PROGRESS, 1993, 9 (06) :671-674
[6]   Chitosan-based delivery systems for protein therapeutics and antigens [J].
Amidi, Maryam ;
Mastrobattista, Enrico ;
Jiskoot, Wim ;
Hennink, Wim E. .
ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) :59-82
[7]  
Andrade Fernanda, 2011, Curr Drug Discov Technol, V8, P157
[8]   5-Flourouracil Loaded N,O-Carboxymethyl Chitosan Nanoparticles as an Anticancer Nanomedicine for Breast Cancer [J].
Anitha, A. ;
Chennazhi, K. P. ;
Nair, S. V. ;
Jayakumar, R. .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2012, 8 (01) :29-42
[9]  
[Anonymous], 2009, BIOL EV MED DEV 5
[10]   Therapeutic application of peptides and proteins: parenteral forever? [J].
Antosova, Zuzana ;
Mackova, Martina ;
Kral, Vladimir ;
Macek, Tomas .
TRENDS IN BIOTECHNOLOGY, 2009, 27 (11) :628-635